{"id":27734,"date":"2025-11-27T15:47:32","date_gmt":"2025-11-27T07:47:32","guid":{"rendered":"https:\/\/tbenews.com\/tbe\/?p=27734"},"modified":"2025-11-27T15:48:11","modified_gmt":"2025-11-27T07:48:11","slug":"snapshot-week-49-2025-n-methyl-d-aspartate-receptor-autoantibodies-are-rare-in-tbe-patients","status":"publish","type":"post","link":"https:\/\/tbenews.com\/tbe\/snapshot-week-49-2025-n-methyl-d-aspartate-receptor-autoantibodies-are-rare-in-tbe-patients\/","title":{"rendered":"Snapshot week 49\/2025<br>N-methyl-D-aspartate receptor autoantibodies are rare in TBE patients"},"content":{"rendered":"<span class=\"cb-itemprop\" itemprop=\"reviewBody\">\n<p class=\"wp-block-paragraph\">Mor\u00e9n S, et al. <br>Low frequency of N-methyl-D-aspartate receptor autoimmunity in tick-borne encephalitis. <em>PLoS One.<\/em> 2025;20:e0334438. doi:10.1371\/journal.pone.0334438<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Various viral infections\u2014such as herpes simplex virus\u2014are known to trigger the development of autoantibodies against the N-methyl-D-aspartate receptor (anti-NMDAR).<br>The NMDAR is a glutamate receptor and calcium ion channel in neurons, playing a key role in synaptic plasticity, learning, and memory.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">To date, the prevalence of anti-NMDAR antibodies in the cerebrospinal fluid (CSF) of patients with tick-borne encephalitis (TBE) has not been systematically investigated. If present, such autoantibodies could contribute to the high frequency of cognitive sequelae observed after TBE.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">In this study, 53 TBE patients aged 18\u201365 years with CSF samples suitable for anti-NMDAR analysis were included. A total of 71 CSF samples were examined: 21 from prospectively enrolled patients and 50 from retrospectively identified cases.<br>The median time from onset of central nervous system (CNS) symptoms to CSF sampling was 91 days.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Only one of the 53 patients (1.9%) tested positive for anti-NMDAR autoantibodies, with two positive CSF samples collected 27 days and 433 days after symptom onset.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Given the high prevalence of cognitive complaints following TBE and the very low frequency of anti-NMDAR positivity, the authors conclude that other mechanisms\u2014rather than NMDAR autoimmunity\u2014are likely to underlie the majority of post-TBE cognitive sequelae.<\/p>\n<\/span>","protected":false},"excerpt":{"rendered":"<p>Mor\u00e9n S, et al. Low frequency of N-methyl-D-aspartate receptor autoimmunity in tick-borne encephalitis. PLoS One. 2025;20:e0334438. doi:10.1371\/journal.pone.0334438 Various viral infections\u2014such as herpes simplex virus\u2014are known to trigger the development of autoantibodies against the N-methyl-D-aspartate receptor (anti-NMDAR).The NMDAR is a glutamate receptor and calcium ion channel in neurons, playing a key role in synaptic plasticity, learning, and memory. To date, the prevalence of anti-NMDAR antibodies in the cerebrospinal fluid (CSF) of patients with tick-borne encephalitis (TBE) has not been systematically investigated. If present, such autoantibodies could contribute to the high frequency of cognitive sequelae observed after TBE. In this study, 53 TBE patients aged 18\u201365 years with CSF samples suitable for anti-NMDAR analysis were included. A total of 71 CSF samples were examined: 21 from prospectively enrolled patients and 50 from retrospectively identified cases.The median time from onset of central nervous system (CNS) symptoms to CSF sampling was 91 days. Only one of the 53 patients (1.9%) tested positive for anti-NMDAR autoantibodies, with two positive CSF samples collected 27 days and 433 days after symptom onset. Given the high prevalence of cognitive complaints following TBE and the very low frequency of anti-NMDAR positivity, the authors conclude that other mechanisms\u2014rather than NMDAR autoimmunity\u2014are likely to underlie the majority of post-TBE cognitive sequelae.<\/p>\n","protected":false},"author":94681,"featured_media":20968,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_monsterinsights_skip_tracking":false,"footnotes":""},"categories":[18],"tags":[1178,1218,1322,1321],"coauthors":[1108],"class_list":["post-27734","post","type-post","status-publish","format-standard","has-post-thumbnail","category-snapshot","tag-autoantibodies","tag-cognitive-sequelae","tag-intrathecal-autoantibodies","tag-n-methyl-d-aspartate-receptor"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.1 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Snapshot week 49\/2025N-methyl-D-aspartate receptor autoantibodies are rare in TBE patients - TBE Book<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/tbenews.com\/tbe\/snapshot-week-49-2025-n-methyl-d-aspartate-receptor-autoantibodies-are-rare-in-tbe-patients\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Snapshot week 49\/2025N-methyl-D-aspartate receptor autoantibodies are rare in TBE patients - TBE Book\" \/>\n<meta property=\"og:description\" content=\"Mor\u00e9n S, et al. Low frequency of N-methyl-D-aspartate receptor autoimmunity in tick-borne encephalitis. PLoS One. 2025;20:e0334438. doi:10.1371\/journal.pone.0334438 Various viral infections\u2014such as herpes simplex virus\u2014are known to trigger the development of autoantibodies against the N-methyl-D-aspartate receptor (anti-NMDAR).The NMDAR is a glutamate receptor and calcium ion channel in neurons, playing a key role in synaptic plasticity, learning, and memory. To date, the prevalence of anti-NMDAR antibodies in the cerebrospinal fluid (CSF) of patients with tick-borne encephalitis (TBE) has not been systematically investigated. If present, such autoantibodies could contribute to the high frequency of cognitive sequelae observed after TBE. In this study, 53 TBE patients aged 18\u201365 years with CSF samples suitable for anti-NMDAR analysis were included. A total of 71 CSF samples were examined: 21 from prospectively enrolled patients and 50 from retrospectively identified cases.The median time from onset of central nervous system (CNS) symptoms to CSF sampling was 91 days. Only one of the 53 patients (1.9%) tested positive for anti-NMDAR autoantibodies, with two positive CSF samples collected 27 days and 433 days after symptom onset. Given the high prevalence of cognitive complaints following TBE and the very low frequency of anti-NMDAR positivity, the authors conclude that other mechanisms\u2014rather than NMDAR autoimmunity\u2014are likely to underlie the majority of post-TBE cognitive sequelae.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/tbenews.com\/tbe\/snapshot-week-49-2025-n-methyl-d-aspartate-receptor-autoantibodies-are-rare-in-tbe-patients\/\" \/>\n<meta property=\"og:site_name\" content=\"TBE Book\" \/>\n<meta property=\"article:published_time\" content=\"2025-11-27T07:47:32+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-11-27T07:48:11+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/tbenews.com\/tbe\/wp-content\/uploads\/2023\/12\/TBE-Snapshots.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1180\" \/>\n\t<meta property=\"og:image:height\" content=\"250\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"logesan\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"logesan\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/tbenews.com\\\/tbe\\\/snapshot-week-49-2025-n-methyl-d-aspartate-receptor-autoantibodies-are-rare-in-tbe-patients\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/tbenews.com\\\/tbe\\\/snapshot-week-49-2025-n-methyl-d-aspartate-receptor-autoantibodies-are-rare-in-tbe-patients\\\/\"},\"author\":{\"name\":\"logesan\",\"@id\":\"https:\\\/\\\/tbenews.com\\\/tbe\\\/#\\\/schema\\\/person\\\/eea00490409f8d848a28485d0f68fac3\"},\"headline\":\"Snapshot week 49\\\/2025 N-methyl-D-aspartate receptor autoantibodies are rare in TBE patients\",\"datePublished\":\"2025-11-27T07:47:32+00:00\",\"dateModified\":\"2025-11-27T07:48:11+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/tbenews.com\\\/tbe\\\/snapshot-week-49-2025-n-methyl-d-aspartate-receptor-autoantibodies-are-rare-in-tbe-patients\\\/\"},\"wordCount\":219,\"publisher\":{\"@id\":\"https:\\\/\\\/tbenews.com\\\/tbe\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/tbenews.com\\\/tbe\\\/snapshot-week-49-2025-n-methyl-d-aspartate-receptor-autoantibodies-are-rare-in-tbe-patients\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/tbenews.com\\\/tbe\\\/wp-content\\\/uploads\\\/2023\\\/12\\\/TBE-Snapshots.jpg\",\"keywords\":[\"autoantibodies\",\"Cognitive sequelae\",\"intrathecal autoantibodies\",\"N-methyl-D-aspartate receptor\"],\"articleSection\":[\"Snapshot\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/tbenews.com\\\/tbe\\\/snapshot-week-49-2025-n-methyl-d-aspartate-receptor-autoantibodies-are-rare-in-tbe-patients\\\/\",\"url\":\"https:\\\/\\\/tbenews.com\\\/tbe\\\/snapshot-week-49-2025-n-methyl-d-aspartate-receptor-autoantibodies-are-rare-in-tbe-patients\\\/\",\"name\":\"Snapshot week 49\\\/2025 N-methyl-D-aspartate receptor autoantibodies are rare in TBE patients - TBE Book\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/tbenews.com\\\/tbe\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/tbenews.com\\\/tbe\\\/snapshot-week-49-2025-n-methyl-d-aspartate-receptor-autoantibodies-are-rare-in-tbe-patients\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/tbenews.com\\\/tbe\\\/snapshot-week-49-2025-n-methyl-d-aspartate-receptor-autoantibodies-are-rare-in-tbe-patients\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/tbenews.com\\\/tbe\\\/wp-content\\\/uploads\\\/2023\\\/12\\\/TBE-Snapshots.jpg\",\"datePublished\":\"2025-11-27T07:47:32+00:00\",\"dateModified\":\"2025-11-27T07:48:11+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/tbenews.com\\\/tbe\\\/snapshot-week-49-2025-n-methyl-d-aspartate-receptor-autoantibodies-are-rare-in-tbe-patients\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/tbenews.com\\\/tbe\\\/snapshot-week-49-2025-n-methyl-d-aspartate-receptor-autoantibodies-are-rare-in-tbe-patients\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/tbenews.com\\\/tbe\\\/snapshot-week-49-2025-n-methyl-d-aspartate-receptor-autoantibodies-are-rare-in-tbe-patients\\\/#primaryimage\",\"url\":\"https:\\\/\\\/tbenews.com\\\/tbe\\\/wp-content\\\/uploads\\\/2023\\\/12\\\/TBE-Snapshots.jpg\",\"contentUrl\":\"https:\\\/\\\/tbenews.com\\\/tbe\\\/wp-content\\\/uploads\\\/2023\\\/12\\\/TBE-Snapshots.jpg\",\"width\":1180,\"height\":250},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/tbenews.com\\\/tbe\\\/snapshot-week-49-2025-n-methyl-d-aspartate-receptor-autoantibodies-are-rare-in-tbe-patients\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/tbenews.com\\\/tbe\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Snapshot week 49\\\/2025N-methyl-D-aspartate receptor autoantibodies are rare in TBE patients\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/tbenews.com\\\/tbe\\\/#website\",\"url\":\"https:\\\/\\\/tbenews.com\\\/tbe\\\/\",\"name\":\"The TBE Book\",\"description\":\"Tick-borne Encephalitis (TBE)\",\"publisher\":{\"@id\":\"https:\\\/\\\/tbenews.com\\\/tbe\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/tbenews.com\\\/tbe\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/tbenews.com\\\/tbe\\\/#organization\",\"name\":\"Global Health Press\",\"url\":\"https:\\\/\\\/tbenews.com\\\/tbe\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/tbenews.com\\\/tbe\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/tbenews.com\\\/tbe\\\/wp-content\\\/uploads\\\/2019\\\/01\\\/logo-PNG.png\",\"contentUrl\":\"https:\\\/\\\/tbenews.com\\\/tbe\\\/wp-content\\\/uploads\\\/2019\\\/01\\\/logo-PNG.png\",\"width\":1000,\"height\":715,\"caption\":\"Global Health Press\"},\"image\":{\"@id\":\"https:\\\/\\\/tbenews.com\\\/tbe\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/tbenews.com\\\/tbe\\\/#\\\/schema\\\/person\\\/eea00490409f8d848a28485d0f68fac3\",\"name\":\"logesan\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/3844852ce7cea119df4cb0d88d8862bd170a41490c4f4b8c784a3ff5d5bed353?s=96&d=mm&r=g23fd037fb0950eb6606e07f441b58289\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/3844852ce7cea119df4cb0d88d8862bd170a41490c4f4b8c784a3ff5d5bed353?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/3844852ce7cea119df4cb0d88d8862bd170a41490c4f4b8c784a3ff5d5bed353?s=96&d=mm&r=g\",\"caption\":\"logesan\"},\"url\":\"https:\\\/\\\/tbenews.com\\\/tbe\\\/author\\\/logesan\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Snapshot week 49\/2025N-methyl-D-aspartate receptor autoantibodies are rare in TBE patients - TBE Book","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/tbenews.com\/tbe\/snapshot-week-49-2025-n-methyl-d-aspartate-receptor-autoantibodies-are-rare-in-tbe-patients\/","og_locale":"en_US","og_type":"article","og_title":"Snapshot week 49\/2025N-methyl-D-aspartate receptor autoantibodies are rare in TBE patients - TBE Book","og_description":"Mor\u00e9n S, et al. Low frequency of N-methyl-D-aspartate receptor autoimmunity in tick-borne encephalitis. PLoS One. 2025;20:e0334438. doi:10.1371\/journal.pone.0334438 Various viral infections\u2014such as herpes simplex virus\u2014are known to trigger the development of autoantibodies against the N-methyl-D-aspartate receptor (anti-NMDAR).The NMDAR is a glutamate receptor and calcium ion channel in neurons, playing a key role in synaptic plasticity, learning, and memory. To date, the prevalence of anti-NMDAR antibodies in the cerebrospinal fluid (CSF) of patients with tick-borne encephalitis (TBE) has not been systematically investigated. If present, such autoantibodies could contribute to the high frequency of cognitive sequelae observed after TBE. In this study, 53 TBE patients aged 18\u201365 years with CSF samples suitable for anti-NMDAR analysis were included. A total of 71 CSF samples were examined: 21 from prospectively enrolled patients and 50 from retrospectively identified cases.The median time from onset of central nervous system (CNS) symptoms to CSF sampling was 91 days. Only one of the 53 patients (1.9%) tested positive for anti-NMDAR autoantibodies, with two positive CSF samples collected 27 days and 433 days after symptom onset. Given the high prevalence of cognitive complaints following TBE and the very low frequency of anti-NMDAR positivity, the authors conclude that other mechanisms\u2014rather than NMDAR autoimmunity\u2014are likely to underlie the majority of post-TBE cognitive sequelae.","og_url":"https:\/\/tbenews.com\/tbe\/snapshot-week-49-2025-n-methyl-d-aspartate-receptor-autoantibodies-are-rare-in-tbe-patients\/","og_site_name":"TBE Book","article_published_time":"2025-11-27T07:47:32+00:00","article_modified_time":"2025-11-27T07:48:11+00:00","og_image":[{"width":1180,"height":250,"url":"https:\/\/tbenews.com\/tbe\/wp-content\/uploads\/2023\/12\/TBE-Snapshots.jpg","type":"image\/jpeg"}],"author":"logesan","twitter_card":"summary_large_image","twitter_misc":{"Written by":"logesan","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/tbenews.com\/tbe\/snapshot-week-49-2025-n-methyl-d-aspartate-receptor-autoantibodies-are-rare-in-tbe-patients\/#article","isPartOf":{"@id":"https:\/\/tbenews.com\/tbe\/snapshot-week-49-2025-n-methyl-d-aspartate-receptor-autoantibodies-are-rare-in-tbe-patients\/"},"author":{"name":"logesan","@id":"https:\/\/tbenews.com\/tbe\/#\/schema\/person\/eea00490409f8d848a28485d0f68fac3"},"headline":"Snapshot week 49\/2025 N-methyl-D-aspartate receptor autoantibodies are rare in TBE patients","datePublished":"2025-11-27T07:47:32+00:00","dateModified":"2025-11-27T07:48:11+00:00","mainEntityOfPage":{"@id":"https:\/\/tbenews.com\/tbe\/snapshot-week-49-2025-n-methyl-d-aspartate-receptor-autoantibodies-are-rare-in-tbe-patients\/"},"wordCount":219,"publisher":{"@id":"https:\/\/tbenews.com\/tbe\/#organization"},"image":{"@id":"https:\/\/tbenews.com\/tbe\/snapshot-week-49-2025-n-methyl-d-aspartate-receptor-autoantibodies-are-rare-in-tbe-patients\/#primaryimage"},"thumbnailUrl":"https:\/\/tbenews.com\/tbe\/wp-content\/uploads\/2023\/12\/TBE-Snapshots.jpg","keywords":["autoantibodies","Cognitive sequelae","intrathecal autoantibodies","N-methyl-D-aspartate receptor"],"articleSection":["Snapshot"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/tbenews.com\/tbe\/snapshot-week-49-2025-n-methyl-d-aspartate-receptor-autoantibodies-are-rare-in-tbe-patients\/","url":"https:\/\/tbenews.com\/tbe\/snapshot-week-49-2025-n-methyl-d-aspartate-receptor-autoantibodies-are-rare-in-tbe-patients\/","name":"Snapshot week 49\/2025 N-methyl-D-aspartate receptor autoantibodies are rare in TBE patients - TBE Book","isPartOf":{"@id":"https:\/\/tbenews.com\/tbe\/#website"},"primaryImageOfPage":{"@id":"https:\/\/tbenews.com\/tbe\/snapshot-week-49-2025-n-methyl-d-aspartate-receptor-autoantibodies-are-rare-in-tbe-patients\/#primaryimage"},"image":{"@id":"https:\/\/tbenews.com\/tbe\/snapshot-week-49-2025-n-methyl-d-aspartate-receptor-autoantibodies-are-rare-in-tbe-patients\/#primaryimage"},"thumbnailUrl":"https:\/\/tbenews.com\/tbe\/wp-content\/uploads\/2023\/12\/TBE-Snapshots.jpg","datePublished":"2025-11-27T07:47:32+00:00","dateModified":"2025-11-27T07:48:11+00:00","breadcrumb":{"@id":"https:\/\/tbenews.com\/tbe\/snapshot-week-49-2025-n-methyl-d-aspartate-receptor-autoantibodies-are-rare-in-tbe-patients\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/tbenews.com\/tbe\/snapshot-week-49-2025-n-methyl-d-aspartate-receptor-autoantibodies-are-rare-in-tbe-patients\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/tbenews.com\/tbe\/snapshot-week-49-2025-n-methyl-d-aspartate-receptor-autoantibodies-are-rare-in-tbe-patients\/#primaryimage","url":"https:\/\/tbenews.com\/tbe\/wp-content\/uploads\/2023\/12\/TBE-Snapshots.jpg","contentUrl":"https:\/\/tbenews.com\/tbe\/wp-content\/uploads\/2023\/12\/TBE-Snapshots.jpg","width":1180,"height":250},{"@type":"BreadcrumbList","@id":"https:\/\/tbenews.com\/tbe\/snapshot-week-49-2025-n-methyl-d-aspartate-receptor-autoantibodies-are-rare-in-tbe-patients\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/tbenews.com\/tbe\/"},{"@type":"ListItem","position":2,"name":"Snapshot week 49\/2025N-methyl-D-aspartate receptor autoantibodies are rare in TBE patients"}]},{"@type":"WebSite","@id":"https:\/\/tbenews.com\/tbe\/#website","url":"https:\/\/tbenews.com\/tbe\/","name":"The TBE Book","description":"Tick-borne Encephalitis (TBE)","publisher":{"@id":"https:\/\/tbenews.com\/tbe\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/tbenews.com\/tbe\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/tbenews.com\/tbe\/#organization","name":"Global Health Press","url":"https:\/\/tbenews.com\/tbe\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/tbenews.com\/tbe\/#\/schema\/logo\/image\/","url":"https:\/\/tbenews.com\/tbe\/wp-content\/uploads\/2019\/01\/logo-PNG.png","contentUrl":"https:\/\/tbenews.com\/tbe\/wp-content\/uploads\/2019\/01\/logo-PNG.png","width":1000,"height":715,"caption":"Global Health Press"},"image":{"@id":"https:\/\/tbenews.com\/tbe\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/tbenews.com\/tbe\/#\/schema\/person\/eea00490409f8d848a28485d0f68fac3","name":"logesan","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/3844852ce7cea119df4cb0d88d8862bd170a41490c4f4b8c784a3ff5d5bed353?s=96&d=mm&r=g23fd037fb0950eb6606e07f441b58289","url":"https:\/\/secure.gravatar.com\/avatar\/3844852ce7cea119df4cb0d88d8862bd170a41490c4f4b8c784a3ff5d5bed353?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/3844852ce7cea119df4cb0d88d8862bd170a41490c4f4b8c784a3ff5d5bed353?s=96&d=mm&r=g","caption":"logesan"},"url":"https:\/\/tbenews.com\/tbe\/author\/logesan\/"}]}},"_links":{"self":[{"href":"https:\/\/tbenews.com\/tbe\/wp-json\/wp\/v2\/posts\/27734","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/tbenews.com\/tbe\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/tbenews.com\/tbe\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/tbenews.com\/tbe\/wp-json\/wp\/v2\/users\/94681"}],"replies":[{"embeddable":true,"href":"https:\/\/tbenews.com\/tbe\/wp-json\/wp\/v2\/comments?post=27734"}],"version-history":[{"count":2,"href":"https:\/\/tbenews.com\/tbe\/wp-json\/wp\/v2\/posts\/27734\/revisions"}],"predecessor-version":[{"id":27736,"href":"https:\/\/tbenews.com\/tbe\/wp-json\/wp\/v2\/posts\/27734\/revisions\/27736"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/tbenews.com\/tbe\/wp-json\/wp\/v2\/media\/20968"}],"wp:attachment":[{"href":"https:\/\/tbenews.com\/tbe\/wp-json\/wp\/v2\/media?parent=27734"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/tbenews.com\/tbe\/wp-json\/wp\/v2\/categories?post=27734"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/tbenews.com\/tbe\/wp-json\/wp\/v2\/tags?post=27734"},{"taxonomy":"author","embeddable":true,"href":"https:\/\/tbenews.com\/tbe\/wp-json\/wp\/v2\/coauthors?post=27734"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}